We examined the sera of patients with Meniere's disease for the presence of antibodies against 8 inner ear antigens by enzyme-linked immunosorbent assay (ELISA). One hundred eight patients with Meniere's disease and 28 control subjects were studied. The antibodies against chicken type II collagen, bovine type II collagen, the cyanogen bromide cleaved peptide 11 (CB11) of each, type IX and XI collagens, C-Raf, and tubulin were measured by ELISA. The sensitivity of each antigen was between 37% and 60% individually, and was 91% when all 8 inner ear antigens were combined. These results showed that 91% of Meniere's disease sera have antibody activities to 1 or more of these inner ear antigens. The results suggest that performing ELISA for these 8 inner ear antigens was useful as a diagnostic tool for Meniere's disease. Further study is required for elucidating the role of these antigens in the pathogenesis of Meniere's disease, which might eventually result in better therapy.
McCabeBF. Autoimmune inner ear disease. In: VeldmanJEMcCabeBFHuizingEHMygindNImmunobiology, autoimmunity, and transplantation in otorhinolaryngology. Amsterdam, the Netherlands: Kugler, 1985: 107–10.
3.
YooTJStuartJMKangAHTownesASTomodaKDixitS. Type II collagen autoimmunity in otosclerosis and Meniere's disease. Science1982; 217: 1153–5.
4.
YooTJYazawaYTomodaKFloydR. Type II collagen-induced autoimmune endolymphatic hydrops in guinea pig. Science1983; 222: 65–7.
5.
TomiyamaSHarrisJP. The endolymphatic sac: Its importance in inner ear immune responses. Laryngoscope1986; 96: 685–91.
6.
ArnoldWPfaltzCR. Critical evaluation of the immune-fluorescence microscopic test for identification of serum antibodies against human inner ear tissue. Acta Otolaryngol (Stockh)1987; 103: 373–8.
7.
HarrisJPSharpPA. Inner ear autoantibodies in patients with rapidly progressive sensorineural hearing loss. Laryngoscope1990; 100: 516–24.
8.
JoliatTSeyerJBernsteinJ. Antibodies against a 30 kilodalton cochlear protein and type II and IX collagens in the serum of patients with inner ear disease. Ann Otol Rhinol Laryngol1992; 101: 1000–6.
9.
HelfgottSMMoscickiRAMartinJS. Correlation between antibodies to type II collagen and treatment outcome in bilateral progressive sensorineural hearing loss. Lancet1991; 337: 387–9.
10.
CaoMYGersdorffMDeggoujNWarnyMTomasiJP. Detection of inner ear disease autoantibodies by immunoblotting. Mol Cell Biochem1995; 146: 157–63.
11.
SuzukiMKrugMSChengKCYazawaYBernsteinJYooTJ. Antibodies against inner ear protein in the sera of patients with inner ear diseases. ORL J Otorhinolaryngol Relat Spec1997; 59: 10–7.
12.
ChengK-CMatsuokaHLeeKM. Proto-oncogene Raf-1 as an autoantigen in Meniere's disease. Ann Otol Rhinol Laryngol2000; 109: 1093–8.
13.
YooTJTanakaHKrugMS. β-Tubulin as an autoantigen in Meniere's disease. ARO Abstracts1999: abstract 825.
14.
PearsonBWBrackmannDE. Committee on Hearing and Equilibrium guidelines for reporting treatment results in Meniere's disease. Otolaryngol Head Neck Surg1985; 93: 579–81.
15.
TeratoKHastyKACremerMAStuartJMTownesASKangAH. Collagen-induced arthritis in mice: Localization of an arthritogenic determinant to a fragment of the type II collagen molecule. J Exp Med1985; 162: 637–46.
16.
StuartJMCremerMAKangAHTownesAS. Collagen-induced arthritis in rats: Evaluation of early immunologic event. Arthritis Rheum1979; 22: 1344–51.
17.
MillerED. Isolation and characterization of the cyanogen bromide peptides from the αI(II) chain of chick cartilage collagen. Biochemistry1971; 10: 3030–5.
18.
ReeseLAMayneR. Minor collagens of chicken hyaline cartilage. Biochemistry1981; 20: 5443–8.
19.
TakedaTSudoNKitanoHYooTJ. Type II collagen-induced autoimmune ear disease in mice: A preliminary report on an epitope of the type II collagen molecule that induced inner ear lesions. Am J Otol1996; 17: 69–75.
20.
YooTJTomodaKHernandezAD. Type II collagen–induced autoimmune inner ear lesions in guinea pigs. Ann Otol Rhinol Laryngol Suppl1984; 93(suppl 113): 3–5.
21.
YooTJTomodaKStuartJMCremerMATownesASKangAH. Type II collagen-induced autoimmune sensorineural hearing loss and vestibular dysfunction in rats. Ann Otol Rhinol Laryngol1983; 92: 267–71.
22.
YooTJYazawaYTomodaKFloydRA. Type II collagen induced autoimmune endolymphatic hydrops in guinea pig. Science1983; 222: 65–7.
23.
SolimanAM. Type II collagen induced inner ear disease: Critical evaluation of the guinea pig model. Am J Otol1990; 11: 127–32.
24.
HuangCSaportaDAbramsonM. Immunologically induced salpingitis in rats. Am J Otolaryngol1985; 6: 368–72.
25.
HuangC. Bone resorption in experimental otosclerosis in rats. Am J Otolaryngol1987; 8: 332–41.
26.
CruzOLMMinitiACossermelliWOliveiraRM. Autoimmune sensorineural hearing loss: A preliminary experimental study. Am J Otol1990; 11: 342–6.
27.
TomodaKMaedaNYamawakiTYamashitaTKumazawaTOhashiT. Immunologically induced experimental hydrops: Its mechanisms and pathology. In: NadolJB2nd International Symposium on Meniere's Disease. Amsterdam, the Netherlands: Kugler, 1989: 165–72.
28.
TomodaKYamawakiTSuzukaYYamashitaTKumazawaT. Inner ear immunology and the changes of charge barrier. Ear Res (Japan)1988; 19: 356–8.
29.
YooTJTomodaK. Type II collagen distribution in rodents. Laryngoscope1988; 98: 1255–60.
30.
SlepeckyNBSavageJEYooTJ. Localization of type II, IX and V collagen in the inner ear. Acta Otolaryngol (Stockh)1992; 112: 611–7.
31.
SlepeckyNBCefarattiLKYooTJ. Type II and type IX collagen form heterotypic fibers in the tectorial membrane of the inner ear. Matrix1992; 11: 80–6.
TomodaKSuzukaYIwaiHYamashitaTKumazawaT. Meniere's disease and autoimmunity: Clinical study and survey. Acta Otolaryngol Suppl (Stockh)1993(suppl 500): 31–4.
34.
KleinRTimplRZanettiFRPlesterDBergPA. High antibody levels against mouse laminin with specificity for galactosyl-(α1–3)galactose in patients with inner ear diseases. Ann Otol Rhinol Laryngol1989; 98: 537–42.
35.
HerdmanRCDMorganKHoldJLRamsdenRT. Type II collagen autoimmunity and Meniere's disease. J Laryngol Otol1993; 107: 994–8.
36.
GuildSR. Observations upon the structure and normal contents of the ductus and saccus endolymphaticus in the guinea pig (Cavia cobahy). Am J Anat1927; 39: 1–4.
37.
Rask-AndersenHStahleJ. Immunodefence of the inner ear? Lymphocyte-macrophage interaction in the endolymphatic sac. Acta Otolaryngol (Stockh)1980; 89: 283–94.
38.
TakahashiMHarrisJP. Anatomic distribution and localization of immunocompetent cells in normal mouse endolymphatic sacs. Acta Otolaryngol (Stockh)1988; 106: 409–16.
39.
BuiHTLinthicumFHHofmanFMBowmanCAHouseWF. An immunohistochemical study of the endolymphatic sac in patients with acoustic tumors. Laryngoscope1989; 89: 775–8.
40.
IchimiyaIKawauchiHFujiyoshiTTanakaTMogiG. Distribution of immunocompetent cells in normal nasal mucosa: Comparisons among germ-free, specific pathogen–free, and conventional mice. Ann Otol Rhinol Laryngol1991: 100: 638–42.
41.
TomiyamaSHarrisJP. The endolymphatic sac: Its importance in inner ear immune response. Laryngoscope1986; 96: 685–91.
42.
TomiyamaSHarrisJP. The role of the endolymphatic sac in the inner ear immunology. Acta Otolaryngol (Stockh)1987; 103: 182–8.
43.
KawauchiHIchimiyaIKanedaNMogiG. Distribution of immunocompetent cells in the endolymphatic sac. Ann Otol Rhinol Laryngol Suppl1992; 101(suppl 157): 39–47.
44.
YooTJLeeMKMinYS. Epitope specificity and T cell receptor usage in type II collagen induced autoimmune ear disease. Cell Immunol1994; 157: 249–62.
45.
RauchSDSanMartinJMoscickiRA. Bovine temporal bones as a source of inner ear antigen. Ann Otol Rhinol Laryngol1992; 101: 688–90.
46.
YamanobeSHarrisJ. Inner ear specific autoantibodies. Laryngoscope1993; 103: 319–25.
47.
YamanobeSHarrisJP. Extraction of inner ear antigens for studies in inner ear autoimmunity. Ann Otol Rhinol Laryngol1993; 102: 22–7.
48.
KosakaKYamanobeSTomiyamaSYagiT. Inner ear autoantibodies in patients with sensorineural hearing loss. Acta Otolaryngol Suppl (Stockh)1995(suppl 519): 176–7.
49.
MoscickiRAMartinJESUninteroCHRauchSDNadolJBJrBlochKJ. Serum antibody to inner ear proteins in patients with progressive hearing loss, correlation with disease activity and response to corticosteroid treatment. JAMA1994; 272: 611–6.
50.
BillingsPBKeithleyEMHarrisJP. Evidence linking the 68 kilodalton antigen identified in progressive sensorineural hearing loss patient sera with heat shock protein 70. Ann Otol Rhinol Laryngol1995; 104: 181–8.
51.
RamakrishnamAArtsHATelianSCareyTE. Assessing human sera for antibodies to the KHR1-3 inner ear antigen and HSP-70 protein. ARO Abstracts1999: abstract 637.
52.
TruneDRKemptenRBMitchellCRHefeneidenSH. Failure of elevated heat shock protein 70 antibodies to alter cochlear function in mice. Hear Res1998; 116: 65–70.
53.
CaoMYDeggoujNGersdorfMTomasiJP. Extraction of guinea pig inner ear antigens and its application for human autoimmune inner ear disease. Laryngoscope1996; 106: 207–12.
54.
GottschlichSBillingsPBKeithleyEMWeismanMHHarrisJP. Assessment of serum antibodies in patients with rapidly progressive sensorineural hearing loss and Meniere's disease. Laryngoscope1995; 105: 1347–52.
55.
VeldmanJFHanadaTMeeuwsenF. Diagnostic and therapeutic dilemmas in rapidly progressive sensorineural hearing loss and sudden deafness. Acta Otolaryngol (Stockh)1993; 113: 303–6.
56.
BlenisJ. Signal transduction via the MAP kinase: Proceed at your own RSK. Proc Natl Acad Sci USA1993; 90: 5889–92.
